It looks like you're using an Ad Blocker.

Please white-list or disable in your ad-blocking tool.

Thank you.


Some features of ATS will be disabled while you continue to use an ad-blocker.


New Hearts From Stem Cells? Not So Fast Says New Study

page: 1

log in


posted on May, 7 2014 @ 07:49 PM
Recently a lot of hype has been surrounding the idea of using stem cells to treat heart complications. This new study published in Nature is disputing the results of preclinical studies conducted on mice and rats. The c-kit protein was identified as the source of heart muscle regeneration in rats and mice, but this new study indicates that the c-kit cells may actually help form capillaries and do not contribute to forming new cardiomyocyt (pumping muscle) cells.

Study urges caution in stem cell clinical trials for heart attack patients

A new study in Nature challenges research data that form the scientific basis of clinical trials in which heart attack patients are injected with stem cells to try and regenerate damaged heart tissue.
Researchers at Cincinnati Children's Hospital Medical Center and the Howard Hughes Medical Institute (HHMI), report May 7 that cardiac stem cells used in ongoing clinical trials – which express a protein marker called c-kit – do not regenerate contractile heart muscle cells at high enough rates to justify their use for treatment.

Including collaboration from researchers at Cedars-Sinai Heart Institute in Los Angeles and the University of Minnesota's Lillehei Heart Institute, the study uncovers new evidence in what has become a contentious debate in the field of cardiac regeneration, according to Jeffery Molkentin, PhD, study principal investigator and a cardiovascular molecular biologist and HHMI investigator at the Cincinnati Children's Heart Institute.

"Our data suggest any potential benefit from injecting c-kit-positive cells into the hearts of patients is not because they generate new contractile cells called cardiomyocytes," Molkentin said. "Caution is warranted in further clinical testing of this method until the mechanisms in play here are better defined or we are able to dramatically enhance the potential of these cells to generate cardiomyocytes."

edit on 7-5-2014 by FriedBabelBroccoli because: 202

posted on May, 8 2014 @ 04:23 PM
This study is seems to be drawing some attention in the medical community so I ought to provide some more info. This treatment was thought to be a breakthrough which would lead to big revenues and prolonged lives, but increasing understanding of the physiology of the human body is increasingly showing that the future is still murky.

Further information concerning using stem cells to treat heart failure;

In Mayo Clinic's breakthrough process, stem cells are harvested from a patient's bone marrow. The stem cells undergo a laboratory treatment that guides them into becoming cardiac cells. The treated cells are then injected into the patient's heart in an effort to grow healthy heart tissue.

The study is the first successful demonstration in people of the feasibility and safety of transforming adult stem cells into cardiac cells, Dr. Terzic says.

This discovery could have implications for millions of people. Cardiovascular disease is the leading cause of death worldwide, according to the World Health Organization. In the U.S. alone, about 5.8 million people have heart failure, and the number is growing, according to the National Institutes of Health.

Stem Cell Therapy: Helping the Body Heal Itself

Repairing the heart with stem cells

There seems to be a rush to put these treatments into practice as quickly as possible while private firms conduct clinical trials without disclosure of the results.

Hopefully different methods of stem cell therapy will yield better results in the future, but this one does not seem as though it is going to take off.


posted on May, 9 2014 @ 04:32 PM
a reply to: FriedBabelBroccoli
Thanks for posting this thread, personally I have an extreme interest in this topic and your findings do not bode well for me.

Grateful for the new information non the less.
Regards, Iwinder


log in